论文信息 - Plasma P‐selectin is an early marker of thromboembolism in COVID‐19 - 字舞流文

Plasma P‐selectin is an early marker of thromboembolism in COVID‐19

N. Hacohen | M. Filbin | Arnav Mehta | K. Kays | Bank G. Fenyves | J. Margolin | M. Goldberg | C. Beakes | Kyle R. Kays | Caroline Beakes

[1] Paul J. Hoover,et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions , 2021, Cell Reports Medicine.

[2] S. Middeldorp,et al. COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year , 2021, The Lancet Haematology.

[3] C. Buske,et al. SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype , 2021, Cell Death & Disease.

[4] Jonathan A Stefely,et al. Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism , 2020, American journal of hematology.

[5] M. Ballesteros,et al. COVID‐19 coagulopathy: An in‐depth analysis of the coagulation system , 2020, European journal of haematology.